AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

CytomX Therapeutics Inc. (CTMX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.85

-0.04 (-4.21%)

At close: Jan 14, 2025, 3:59 PM

0.84

-1.07%

Pre-market Jan 15, 2025, 06:50 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Revenue	101.21M	53.16M	69.57M	100.36M	57.49M	59.50M	71.62M	15.04M	7.71M	5.08M	888.00K
Cost of Revenue	n/a	5.86M	5.84M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	101.21M	47.31M	63.73M	100.36M	57.49M	59.50M	71.62M	15.04M	7.71M	5.08M	888.00K
Operating Income	-6.48M	-101.33M	-83.78M	-48.60M	-110.89M	-77.87M	-46.26M	-59.59M	-33.20M	-29.77M	-14.96M
Interest Income	9.84M	1.68M	255.00K	1.84M	8.37M	7.64M	2.67M	2.42M	1.31M	7.00K	6.00K
Pretax Income	3.32M	-99.32M	-83.61M	-46.80M	-102.67M	-70.30M	-43.61M	-58.92M	-35.36M	-30.30M	-15.13M
Net Income	-569.00K	-97.30M	-80.65M	-32.88M	-102.24M	-84.60M	-43.10M	-58.90M	-35.37M	-30.31M	-15.14M
Selling & General & Admin	30.02M	42.85M	39.16M	36.03M	36.77M	33.51M	25.61M	19.87M	12.56M	6.54M	4.95M
Research & Development	77.68M	111.65M	114.19M	112.94M	131.62M	103.87M	92.28M	54.76M	28.36M	28.30M	10.89M
Other Expenses	n/a	340.00K	-83.00K	-27.00K	-135.00K	-68.00K	-27.00K	-69.00K	-1.74M	-55.00K	71.00K
Operating Expenses	107.70M	154.50M	153.35M	148.97M	168.38M	137.38M	117.88M	74.63M	40.91M	34.84M	15.84M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.69M	1.73M	487.00K	254.00K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	107.70M	154.50M	153.35M	148.97M	168.38M	137.38M	117.88M	74.63M	40.91M	34.84M	15.84M
Income Tax	3.89M	-2.02M	-2.96M	-13.91M	-427.00K	14.30M	-513.00K	-19.00K	10.00K	10.00K	10.00K
Shares Outstanding (Basic)	73.81M	65.74M	64.15M	46.15M	45.34M	41.66M	37.17M	36.23M	8.60M	34.92M	34.92M
Shares Outstanding (Diluted)	73.81M	65.74M	64.15M	46.15M	45.34M	41.66M	37.17M	36.23M	8.60M	34.92M	34.92M
EPS (Basic)	-0.01	-1.48	-1.26	-0.71	-2.26	-2.03	-1.16	-1.63	-4.12	-0.87	-0.43
EPS (Diluted)	-0.01	-1.48	-1.26	-0.71	-2.26	-2.03	-1.16	-1.63	-4.12	-0.87	-0.43
EBITDA	-4.31M	-98.89M	-113.34M	-77.97M	-138.88M	-75.99M	-41.97M	-57.85M	-32.43M	-29.03M	-14.22M
Depreciation & Amortization	2.17M	5.86M	5.84M	5.46M	2.60M	1.88M	1.65M	1.73M	1.21M	783.00K	655.00K